Home › Compare › CHYMF vs ABBV
CHYMF yields 2.34% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, CHYMF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CHYMF + ABBV for your $10,000?
Cahya Mata Sarawak Berhad, an investment holding company, engages in the manufacturing and trading of cement and construction materials, construction, road maintenance, township, and property and infrastructure development businesses in Malaysia. It operates through seven segments: Cement, Construction Materials and Trading, Road Maintenance, Construction, Property Development, Phosphate, and Samalaju Development. The company offers Portland cement; clinker and ready-mix concrete products; pre-cast concrete products, including pre-stressed beams for bridges and other uses, reinforced concrete square piles, box culverts, kerbs, and cement sand bricks; and industrialized building systems, such as wall panels, pre-cast columns and beams, half slabs, hollow blocks, and staircases. It also provides microtonalite, granite, and limestone; delivery, grading, and pavement laying services; steel drawn wires and wire mesh; residential, commercial, and township development, management, and consultancy services; management of temporary accommodation services; supervisory, general trading, software and IT support, education, technical, machinery, and motor vehicle rental services; rehabilitation and maintenance for roads; and construction and road maintenance equipment, as well as supplies premix and road maintenance contractor works. In addition, the company undertakes general construction and infrastructure projects; distributes road and general construction materials, water treatment materials, electrical pipes equipment, and mechanical spare parts; rents investment properties; owns and operates hotels and lodges; and manufactures food, feed, and fertilizer phosphate products. Further, it engages in the mixed-use development and project management activities; and construction of telecommunication towers, as well as undertakes civil engineering, building, and utilities works. The company was founded in 1974 and is headquartered in Kuching, Malaysia.
Full CHYMF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.